by Jordana Choucair | Jul 11, 2022 | Life Sciences
HRA Pharma asked the Food and Drug Administration (FDA) to authorize its birth control pill for over-the-counter sales, the first such application in the U.S., which comes just weeks after the fall of Roe v. Wade. The drugmaker’s chief strategic and innovations...
by Jordana Choucair | Jul 11, 2022 | Providers
The American Hospital Association (AHA) said that the CMS’ new payment model for post-acute care providers has “fundamental flaws.” The model, which was outlined in a report to Congress, would base payments on several factors related to the cost of care and...
by Jordana Choucair | Jul 8, 2022 | Access & Coverage
House Republicans are examining if they want to pursue a national-level abortion ban if they win the House majority next year, with a 15-week ban or further on the table. House Republicans previously passed the Pain-Capable Unborn Child Protection Act, which would ban...
by Jordana Choucair | Jul 8, 2022 | D.C. News
President Joe Biden will sign an executive order today that aims to shore up abortion rights. The order specifically protects access to medication abortion and emergency contraception, bolster patient privacy and legal options, and directs Health and Human Services...
by Jordana Choucair | Jul 8, 2022 | Life Sciences
Beginning next year, pharmaceutical companies must repay Medicare for any injectable and infused drugs that come in single-dose vials and go unused, in a bid to cut down on the billions of dollars that are wasted every year on discarded drugs. Drug companies that...
Recent Comments